Canada markets closed

Lixte Biotechnology Holdings, Inc. (LIXT)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.7650-0.0250 (-0.90%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.28M
Enterprise Value 5.57M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)12.68
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.10

Trading Information

Stock Price History

Beta (5Y Monthly) -0.29
52-Week Change 3-54.26%
S&P500 52-Week Change 325.38%
52 Week High 39.5000
52 Week Low 31.5800
50-Day Moving Average 32.8988
200-Day Moving Average 32.5700

Share Statistics

Avg Vol (3 month) 3581.66k
Avg Vol (10 day) 310.43k
Shares Outstanding 52.25M
Implied Shares Outstanding 62.25M
Float 81.98M
% Held by Insiders 120.48%
% Held by Institutions 14.97%
Shares Short (Apr 15, 2024) 482.65k
Short Ratio (Apr 15, 2024) 40.05
Short % of Float (Apr 15, 2024) 43.77%
Short % of Shares Outstanding (Apr 15, 2024) 43.67%
Shares Short (prior month Mar 15, 2024) 419.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 20, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jun 05, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-64.47%
Return on Equity (ttm)-111.07%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-5.09M
Diluted EPS (ttm)-2.6600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.2M
Total Cash Per Share (mrq)1.87
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)13.73
Book Value Per Share (mrq)0.22

Cash Flow Statement

Operating Cash Flow (ttm)-4.29M
Levered Free Cash Flow (ttm)-2.4M